ストックスクリーナーアプリを入手
215.84
1.90%
4.03
プレマーケット:
215.84
前日終値:
$211.81
開ける：
$212.03
24時間の取引高:
4.77M
Relative Volume:
1.05
時価総額：
$151.73B
収益：
$24.78B
当期純損益:
$3.68B
株価収益率:
41.71
EPS:
5.1743
ネットキャッシュフロー:
$5.29B
1週間 パフォーマンス:
+6.19%
1か月 パフォーマンス:
-1.38%
6か月 パフォーマンス:
+13.99%
1年 パフォーマンス:
+11.67%
1日の値動き範囲:
$209.60
$216.19
1週間の範囲:
$202.62
$216.19
52週間の値動き範囲:
$160.93
$242.80
Danaher Corp Stock (DHR) Company Profile
名前
Danaher Corp
セクター
電話
(202) 828-0850
住所
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, NTRA, A, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
215.84 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
658.76 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
NTRA
Natera Inc
|
370.64 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
161.94 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
269.88 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-02 | 開始されました | Morgan Stanley | Overweight |
| 2025-10-08 | ダウングレード | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-03-21 | アップグレード | Goldman | Neutral → Buy |
| 2025-03-14 | アップグレード | Stifel | Hold → Buy |
| 2025-02-03 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-13 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-31 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-17 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2023-12-18 | 開始されました | HSBC Securities | Hold |
| 2023-12-13 | 再開されました | Wolfe Research | Peer Perform |
| 2023-12-07 | ダウングレード | Goldman | Buy → Neutral |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-05-01 | 開始されました | SVB Securities | Outperform |
| 2023-04-26 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-04-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-10-24 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-08-17 | 再開されました | Bernstein | Outperform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2022-06-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | 開始されました | Bernstein | Outperform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-10 | 繰り返されました | BofA Securities | Buy |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-23 | 繰り返されました | Goldman | Buy |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-04-07 | 再開されました | Robert W. Baird | Outperform |
| 2021-03-03 | 再開されました | Barclays | Overweight |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-25 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | 繰り返されました | Needham | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 再開されました | Stifel | Hold |
| 2019-10-28 | 繰り返されました | Needham | Buy |
| 2019-10-14 | 再開されました | Credit Suisse | Outperform |
| 2019-07-19 | 繰り返されました | Needham | Buy |
| 2019-06-11 | 開始されました | Piper Jaffray | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-04-17 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2019-02-25 | アップグレード | Janney | Neutral → Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-04-20 | 繰り返されました | Stifel | Buy |
すべてを表示
Danaher Corp (DHR) 最新ニュース
Danaher Corp. stock holds near USD 200 as investors eye earnings and guidance - ad-hoc-news.de
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
UBS assumes coverage on Danaher stock with buy rating, $250 target - Investing.com Nigeria
Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says - Yahoo Finance
Danaher Corp. stock gains support from UBS buy rating and July earnings beat - ad-hoc-news.de
Danaher (DHR) Stock Forecast and Price Target 2026 $DHR - MarketBeat
Danaher stock heads into the open after a 0.87 percent slip - ad-hoc-news.de
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Danaher stock holds near $207 after Q2 beat - ad-hoc-news.de
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK
Danaher stock heads into the open after a 0.5 percent dip - ad-hoc-news.de
Danaher Corp stock edges lower as investors weigh latest analyst targets and dividend signal - ad-hoc-news.de
Danaher (NYSE:DHR): Is Its Next Move Tied to Inflation Data? - Kalkine Media
Danaher stock holds after Q2 revenue and EPS beat - AD HOC NEWS
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Danaher Corp. stock trades near 52-week highs as investors digest recent earnings - AD HOC NEWS
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Danaher (DHR) Seen Deftly Navigating AI Integration - Yahoo Finance
Baird Adjusts Price Target on Danaher to $238 From $232, Keeps Outperform Rating - marketscreener.com
Danaher (DHR) Stock Trades Near Fair Value But At An Earnings Premium - Yahoo Finance
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher Corp. stock holds steady after recent pullback as investors weigh Q2 2026 results - AD HOC NEWS
Danaher (DHR) Stock Looks Fairly Valued On Cash Flow Yet Overvalued On Earnings - simplywall.st
A Look at Danaher Corp (DHR) After 3.1% Decline -- GF Value $242 - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Danaher Corp Stock (DHR) Moved Down by 3.06% on Sep 1: Facts Behind the Movement - TradingKey
HSBC Adjusts Price Target on Danaher to $250 From $230, Maintains Buy Rating - marketscreener.com
Danaher Corp. stock underperforms Monday when compared to competitors - MarketWatch
Is Danaher Stock Underperforming the Nasdaq? - Barchart.com
Why Danaher (DHR) Remains a Healthcare Compounder to Watch - Yahoo Finance
Danaher Rides on Strength in Biotechnology Segment: Will It Sustain? - Eastern Progress
Danaher president & CEO Rainer Blair sells $12.7 million in company stock - investing.com
Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside? - Yahoo Finance
Danaher (NYSE: DHR) holder Blair plans $12.7M stock sale - Stock Titan
Resilient Danaher stock edges higher as institutional buying and analyst support frame the outlook - Ad-hoc-news.de
U.S. Market Edge Lower— Danaher Corporation's Bullish Breakout in Focus - kalkine.ca
6,796 Shares in Danaher Corporation $DHR Bought by Portfolio Design Labs LLC - MarketBeat
17 CAPITAL PARTNERS, LLC's Danaher Corp(DHR) Holding History - GuruFocus
10,799 Shares in Danaher Corporation $DHR Acquired by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Somerville Kurt F Purchases Shares of 45,245 Danaher Corporation $DHR - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Makes New Investment in Danaher Corporation $DHR - MarketBeat
932,220 Shares in Danaher Corporation $DHR Bought by Bank of New York Mellon Corp - MarketBeat
Bank of New York Mellon Corp Purchases New Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Danaher (NYSE:DHR) Valuation Debate Deepens After Life Sciences Progress - Kalkine Media
Integrated DNA Technologies Defines the Next Era of DNA Synthesis: Full-Spectrum Capabilities for Speed, Complexity and Scale - StreetInsider
Madison Asset Management LLC Acquires Shares of 448,611 Danaher Corporation $DHR - MarketBeat
Puzo Michael J Makes New Investment in Danaher Corporation $DHR - MarketBeat
Kentucky Farm Bureau Mutual Insurance Co Buys New Position in Danaher Corporation $DHR - MarketBeat
Tocqueville Asset Management L.P. Purchases Shares of 59,318 Danaher Corporation $DHR - MarketBeat
Danaher Corp (DHR) 財務データ
収益
当期純利益
現金流量
EPS
1.12%
大文字化:
|
ボリューム (24 時間):